Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Recombinant was made available for all patients in Wales from 1997.

  • Read more about Recombinant was made available for all patients in Wales from 1997.

Dr Kenneth Calman, CMO, was quoted in a Department of Health press release as saying he was satisfied that there was no scientific evidence of a link between meat eating and development of CJD,

  • Read more about Dr Kenneth Calman, CMO, was quoted in a Department of Health press release as saying he was satisfied that there was no scientific evidence of a link between meat eating and development of CJD,

Transmission studies in combination with surveillance data provided "compelling evidence" of a link between BSE and vCJD.

  • Read more about Transmission studies in combination with surveillance data provided "compelling evidence" of a link between BSE and vCJD.

A witness described her husband being refused endoscopies due to vCJD risk, and they ended up having to book a private appointment for his treatment, costing thousands of pounds.

  • Read more about A witness described her husband being refused endoscopies due to vCJD risk, and they ended up having to book a private appointment for his treatment, costing thousands of pounds.

The Working Party of the Committee on Proprietary Medicinal Products supported the UK recommendation that there should be a recall of batches of blood products if a blood donation to a plasma pool was subsequently found to have been made from a person who developed nvCJD.

  • Read more about The Working Party of the Committee on Proprietary Medicinal Products supported the UK recommendation that there should be a recall of batches of blood products if a blood donation to a plasma pool was subsequently found to have been made from a person who developed nvCJD.

A witness told the inquiry that he had needed his gallbladder removed having been infected with Hepatitis C and the surgeon told him "You are an expensive patient. We had to archive everything in the theatre because you have a variant CJD risk".

  • Read more about A witness told the inquiry that he had needed his gallbladder removed having been infected with Hepatitis C and the surgeon told him "You are an expensive patient. We had to archive everything in the theatre because you have a variant CJD risk".

Whereas people who had received transfusions were only notified if a donor went on to be diagnosed with vCJD, patients undergoing surgery or endoscopy were now to be asked if they had received blood transfusions from 80 or more donors since 1980 and considered at increased risk if so.

  • Read more about Whereas people who had received transfusions were only notified if a donor went on to be diagnosed with vCJD, patients undergoing surgery or endoscopy were now to be asked if they had received blood transfusions from 80 or more donors since 1980 and considered at increased risk if so.

It had been identified that three patients had developed vCJD almost certainly as a consequence of receiving blood transfusions.

  • Read more about It had been identified that three patients had developed vCJD almost certainly as a consequence of receiving blood transfusions.

The Creutzfeldt-Jakob Disease Incidents Panel produced a report recommending which groups should be told they had an increased risk of vCJD for public health purposes from implicated plasma, and setting out notification timelines.

  • Read more about The Creutzfeldt-Jakob Disease Incidents Panel produced a report recommending which groups should be told they had an increased risk of vCJD for public health purposes from implicated plasma, and setting out notification timelines.

An ad hoc meeting was organised at the Royal College of Physicians of Edinburgh which noted that there was a need to consider what plasma fractionators should do, and that because the level of BSE in the UK was significantly higher than in other countries "it may thus be appropriate to be proactive in this area."

  • Read more about An ad hoc meeting was organised at the Royal College of Physicians of Edinburgh which noted that there was a need to consider what plasma fractionators should do, and that because the level of BSE in the UK was significantly higher than in other countries "it may thus be appropriate to be proactive in this area."

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 583
  • Page 584
  • Page 585
  • Page 586
  • Current page 587
  • Page 588
  • Page 589
  • Page 590
  • Page 591
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.